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Prostate cancer
To prevent unnecessary and expensive treatment of benign prostate
cancer, more sensitive tools are needed. Metabolomics combined
with datamining have shown great potential for locating motifs and
biomarkers for prostate cancer. [1]
The aim of this project is to use metabolic data to distinguish
between aggressive and benign prostate cancer cell lines. Four cell
lines are analysed: PC3 and DU145 (aggressive), and Ln-Cap and
PNT1a (non-aggressive).
A.B. Frahma, E. Lundsgaarda, A. Matei, P. Rose Jensena, M. Karlssona, 
J.H. Ardenkjær-Larsena and M.H. Lerchea
aDTU Electro, Technical University of Denmark, Lyngby, Denmark
Email: afrahm@elektro.dtu.dk
Random Forest Feature Extraction
PC-DFA results
References:
[1] Roberts et al. NMR-based metabolomics: Global analysis of                                                        
metamolites to address problems in prostate cancer , (2014)
[2] Lerche et al, Analytical chemistry, 1, 90 (2017)
.
Random Forest (RF) analysis was used to examine what 
features are important for differentiating between the cell lines. 
Results are shown in fig. 3 below.
Figure 3. Graphs showing how useful each peak in the peak data (left) 
and each metabolite in met. data (right) is for the RF classification model.
Metabolic fingerprint 
Cells were incubated for 30 minutes with 13C6-d7 isotope 
labeled glucose, before metabolites were harvested and 
hyperpolarized with dissolution Dynamic Nuclear Polarization 
(dDNP).  This technique has been shown to be quantitative and 
reproducible. [2] From the resulting spectra, integrals of peaks 
were measured and two dataset were generated. One with 
standardized peak values for each peak outside the glucose 
area (peak data) and one where these peaks were collected to 
metabolites (met. data).
b
a
Figure 1: Spectrum from [cell line] cells. Peaks measured for peak data 
(a) and met. Data (b)
Results from Principal Component-Discriminant Function Analysis (PC-DFA) are shown in fig.2 and summarized in table 1. With 
leave-One-Out cross-validation classification of aggressive v. non-aggressive is 96.6% correct for peak data and 93.1% for met. 
data.
Peak data Met. Data
No validation 
Predicted class
No validation 
Predicted class
DU145 PC3 Ln-CAP PNT1a DU145 PC3 Ln-CAP PNT1a
T
ru
e
 c
la
s
s DU145 8 1 0 0
T
ru
e
 c
la
s
s DU145 8 1 0 0
PC3 0 7 0 0 PC3 0 7 0 0
Ln-CAP 0 0 6 0 Ln-CAP 0 0 6 0
PNT1a 0 0 0 7 PNT1a 0 0 1 6
Cross-Validation
Predicted class
Cross-Validation
Predicted class
DU145 PC3 Ln-CAP PNT1a DU145 PC3 Ln-CAP PNT1a
T
ru
e
 c
la
s
s DU145 4 4 0 1
T
ru
e
 c
la
s
s DU145 4 5 0 0
PC3 2 5 0 0 PC3 3 4 0 0
Ln-CAP 0 0 5 1 Ln-CAP 0 1 4 1
PNT1a 0 0 2 5 PNT1a 1 0 1 5
Figure 2: PC-DFA model for peak data (left) and met. data (right). Discriminant function 
axes are made to optimize distance between classes. Circles mark 2 standard deviations.
Biomarkers and classification
Table 1: Results of PC-DFA classification.
These result shows a great potential for classification of 
aggressiveness in prostate cancer by a PC-DFA model trained 
on dDNP NMR metabolomics data. RF can be used to identify 
biomarkers through feature extraction, and feature extraction 
can additionally be used for limiting the number of features 
used for training the PC-DFA model, possibly making a it more 
predictive and less likely to overfit.
Future work could be to obtain metabolic fingerprints from 
prostate cells taken from biopsies on cancer patients, to 
investigate if the model also works on non-lab cell strains. 
